Lineage Cell Therapeutics
LCTX
#8221
Rank
A$0.23 B
Marketcap
$1.27
Share price
1.22%
Change (1 day)
-36.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of June 2024 : A$0.15 B

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are A$0.15 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$0.14 B-18.41%
2022-12-31A$0.18 B-24.52%
2021-12-31A$0.24 B71.49%
2020-12-31A$0.14 B-21.67%
2019-12-31A$0.17 B24.19%
2018-12-31A$0.14 B-34.97%
2017-12-31A$0.22 B12.19%
2016-12-31A$0.19 B52.22%
2015-12-31A$0.12 B41.98%
2014-12-31A$91.52 M41.41%
2013-12-31A$64.72 M126.09%
2012-12-31A$28.62 M-35.95%
2011-12-31A$44.69 M-14.77%
2010-12-31A$52.44 M250.72%
2009-12-31A$14.95 M918.88%
2008-12-31A$1.46 M632.8%
2007-12-31A$0.2 M-75.73%
2006-12-31A$0.82 M-69.17%
2005-12-31A$2.67 M36.15%
2004-12-31A$1.96 M36.39%
2003-12-31A$1.44 M-45.71%
2002-12-31A$2.65 M-30.19%
2001-12-31A$3.8 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$0.48 B 219.94%๐Ÿ‡บ๐Ÿ‡ธ USA